Yiping Mou

机构：Zhejiang Provincial People's Hospital, Hangzhou Medical College

发表论文 217 篇 · 总被引 4005 次 · h-index 38

代表论文

• First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer (2025 · JAMA · 被引 73)
• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 41)
• Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study (2025 · Journal of Clinical Oncology · 被引 37)
• Intraperitoneal and intravenous paclitaxel plus S-1 versus intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis: Results from the multicenter, randomized, phase 3 DRAGON-01 trial. (2025 · Journal of Clinical Oncology · 被引 28)
• Targeting ion channels: innovative approaches to combat cancer drug resistance (2024 · Theranostics · 被引 28)
• Oxidative balance scores and gallstone disease: mediating effects of oxidative stress (2025 · Nutrition Journal · 被引 10)